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Scheme S1
Hz, J = 1.6 Hz, 1H), 7.37 (t, J = 7. Compound 6e was prepared using compound 5 and 4,4'-bis(bromomethyl)biphenyl following the same procedure described for synthesis of 6b. Compound 6l was prepared using compound 5 and 3-(bromomethyl)benzonitrile. following the same procedure described for synthesis of 6b. Compound 6n was prepared using compound 5b and 3-(bromomethyl)benzoic acid following the same procedure described for synthesis of 6b. Compound 6o was prepared using compound 5b and 4-methoxybenzyl bromide following the same procedure described for synthesis of 6b, (see Scheme S1). Compound 6p was prepared using compound 5c and 4-methoxybenzyl bromide following the same procedure described for synthesis of 6o according to Scheme S1. Compound 6q was prepared using compound 5d and 4-methoxybenzyl bromide following the same procedure described for synthesis of 6o according to Scheme S1. 3. Compounds 8a and 8c were prepared using compounds 3a and 7 following the same procedure described for synthesis of 4. 
8b 8d

6-bromo-1-[(3-methoxyphenyl)methyl] benzimidazole (8b) and 5-bromo-1-[(3-methoxyphenyl)methyl] benzimidazole (8d).
Compounds 8b and 8d were prepared using compound 3b and 7 following the same procedure described for synthesis of 4.
They were purified by flash chromatography using EtOAc/hexane (25:75) as eluent. 8b
was obtained as a white powder (250.4mg, 32% 
9a
Methyl 3-[[6-(1H-indol-6-yl)benzimidazol-1-yl]methyl] benzoate (9a). Compound 9a
was prepared using compound 8a and indole-6-boronic acid following the same procedure described for synthesis of 5. 
5-(1H-indol-6-yl)-1-[(3-methoxyphenyl)methyl]benzimidazole (9d). Compound 9d
was prepared using compound 8d and indole-6-boronic acid following the same procedure described for synthesis of 5. 
tert-Butyl 6-bromo-3-[(m-methoxyphenyl)methyl]-1H-indole-1-carboxylate (12b).
Compound 12b was prepared using 11b (1.49 g, 4.71 mmol) following the same procedure described for synthesis of 12a. 
tert-Butyl 3-[(3-methoxycarbonylphenyl)methyl]-6-[1-[(3-methoxyphenyl)methyl] indol-6-yl]indole-1-carboxylate (S1).
Compound S1 was prepared using 13a (206 mg, 0.429 mmol) following the same alkylation conditions described for synthesis of 6a.
Following purification by silica gel chromatography (20% EtOAc/hexanes) afforded S1
(184 mg, 71%) as a colorless oil. Data for S1: R f 0. 
Methyl 3-[[6-[1-[(3-methoxyphenyl)methyl]indol-6-yl]-1H-indol-3-yl]methyl]benzoate (S2
3-[[6-[1-[(3-Methoxyphenyl)methyl]indol-6-yl]-1H-indol-3-yl]methyl]benzoic acid (14a).
Compound 14a was prepared using S2 (143 mg, 0.286 mmol) following the same saponification procedure described for synthesis of 6a. 
tert-Butyl 6-[1-[(3-methoxycarbonylphenyl)methyl]indol-6-yl]-3-[(3-methoxyphenyl)
methyl]indole-1-carboxylate (S3). Compound S3 was prepared using 13b (231 mg, 0.510 mmol) following the same alkylation conditions described for synthesis of 6a.
Following purification by silica gel chromatography (20% EtOAc/hexanes) afforded S3 
3-[[6-[3-[(3-methoxyphenyl)methyl]-1H-indol-6-yl]indol-1-yl]methyl]benzoic acid (14b
tert-Butyl 6-[3-[(3-methoxycarbonylphenyl)methyl]-1H-indol-6-yl]-3-[(3-methoxy phenyl)methyl]indole-1-carboxylate (S5
3-[[6-[3-[(3-Methoxyphenyl)methyl]-1H-indol-6-yl]-1H-indol-3-yl]methyl]benzoic acid (14c).
Compound 14c was prepared using S6 (87.4 mg, 0.175 mmol) following the same saponification procedure described for synthesis of 6a. 
5,5'-Biindole (15).
Compound 15 was prepared using 5-bromoindole (2b) (400 mg, 2.04 mmol) following the same Suzuki coupling procedure described for synthesis of 5. 
3-[[5-[3-[(3-Methoxycarbonylphenyl)methyl]-1H-indol-5-yl]-1H-indol-3-yl]methyl] benzoic acid (16).
Compound 16 was prepared using S7 (73.4 mg, 0.139 mmol)
following the same saponification procedure described for synthesis of 6a, but reducing the reaction time to 1 h. Following purification by silica gel chromatography (9% Figure S1A
1D NMR spectra of the four benzimidazole intermediates. 5-and 6-bromo isomers were separated by flash chromatography. Assignments were based on COSY and ROESY spectra (see Figure S1B ) and peak multiplicity. * impurity in 8b, ~10% of 8d.
Figure S1B
Sections of ROESY spectra of benzimidazole intermediates (structure above) showing cross peaks to the methylene protons. Assignments of 5-and 6-bromo isomers was based on observation of a ROESY cross peak to the proton at position 7, which is a singlet in 6-bromobenzimidazoles and a doublet in 5-bromobenzimidazoles, providing clear identification of the isomers. * impurity in 8b, ~10% of 8d. OEChemscore: A sum of lipophilic interactions, hydrogen bond and metal interactions between donors and acceptors and a clash penalty for clashes between ligand and protein.
Screenscore: A sum of lipophilic and ambiguous steric interactions, a clash penalty for clashes with the protein, PLP, a steric contribution identical to the steric component of PLP, hydrogen bond interactions between acceptors and donors, aromatic interactions between phenyl groups and methyls, amides or hydrogens on aromatic rings and a penalty for rotatable bonds.
Zapbind A scoring function which uses PB electrostatic calculations in combination with an area contact term.
Figure S4
OEChemScore plotted against observed hydrophobic pocket binding pK I for molecules in Tables 1 and 2 . Scores of the lowest energy conformer selected by FRED docking are included for three categories described in the text: 1) 6-6' linked bisindole compounds, 3-substituted bisindoles with complementary shape and all 3 ring systems (black); 2) benzimidazole containing compounds and alternatively linked bisindole compounds (red);
3) Outliers not included in the calculation of correlation coefficient (green). 
